Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Trivedi Science™ Announces the Beginning of Their Science Research to Create Highly Effective Pharmaceutical Drugs with Minimal Side Effects
  • USA - English


News provided by

Trivedi Global Inc.

Apr 28, 2015, 03:00 ET

Share this article

Share toX

Share this article

Share toX


Henderson, NV (PRWEB) April 28, 2015 -- According to Professor Donald W. Light from Harvard University's Center for Ethics (June 27, 2014), prescription drugs are the fourth leading cause of death in the world. Medical Science is becoming increasingly aware of the limitations and dangers of current pharmaceutical drugs available on the market, such as chemotherapy drugs to treat cancer, Prozac for depression and antibiotics used to treat bacteria that are quickly evolving to become increasingly resistant to current drugs and medicine.

With these astounding results and the impressive compilation of supporting science research, human health care is highly anticipating the impact The Trivedi Effect® will have on Pharmaceuticals, Nutraceuticals and the rest of the world.

Post this

The U.S. National Library of Medicine National Institutes of Health states that current drugs available on the market either have problems in terms of high toxicity, poor solubility, bioavailability and permeability, or are quickly being metabolized and excreted by the body’s biological systems [1 (July 5, 2012). Therefore, in order to create sufficient therapeutic effects, the drugs need to be administered in high (and often very toxic) doses. Even so, once the drug enters into the body there is no guarantee that it will reach the intended site of action, leading to exposure to the toxic effects of the drugs with very limited therapeutic impact. Even if the drug does reach the intended site of action, there is no certainty that the drug will have a sufficient impact. However, Trivedi Science™ is beginning new studies which, based on their previous successful scientific studies in the areas of Materials Science and experiments on pharmaceutical and nutraceutical compounds (available at http://www.trivediscience.com/pharma/), show that The Trivedi Effect® may be able to address all of these issues and alter pharmaceutical and nutraceutical compounds to reduce their toxicity and greatly increase their shelf life, bioavailability, solubility and system of drug release, leading to minimal side effects, lower doses and greater biological receptivity with full therapeutic impact.

Since discovering The Trivedi Effect® in 1995, Mahendra Kumar Trivedi started Trivedi Science™ to research, test and prove the impact of The Trivedi Effect® on living and nonliving materials, which has compiled into a hefty number of nearly 4,000 scientific studies in different fields of Life Sciences and Materials Sciences, such as agriculture, biotechnology, microbiology, genetics, cancer and materials science. Their impressive collection of science research has also led to many publications in international scientific peer-reviewed journals, and they currently have many more publications that have been confirmed and are underway. All science research and publications are available at http://www.trivediscience.com.

Based on the results in Materials Science and The Trivedi Effect®’s capability to transform everything on the cellular, molecular and atomic levels, Trivedi Science™ is expecting extraordinary results in the areas of pharmaceutical and nutraceutical compounds, which may provide a permanent solution to the most prominent needs of the current market of drugs and medicine.

Mr. Trivedi has announced that Trivedi Science™ is promoting further testing and research in the pharmaceutical and nutraceutical arena, especially for anticancer and antibiotic drugs, and has already found over 7 different U.S. FDA approved laboratories to begin the process of experimentation, research, analytics, mice model studies and preclinical trials. This could lead to new, advanced and highly effect pharmaceutical drugs and nutraceutical drugs without any of the current hurdles the drug market now faces. It will be a true revolution for Medical Science and human health care.

Mahendra Trivedi and his wife, Trivedi Master™ Dahryn Trivedi, are already making a profound impact in the human wellness industry through their company Trivedi Master Wellness™ and their Master Wellness Programs™: http://www.trivedimasterwellness.com. Trivedi Master™ and CEO of Trivedi Global Inc., Alice Branton says that Trivedi Master Wellness™ has been able to address the issues of over 200,000 people worldwide in a way that no other model of medical health care or alternative healing modality has done before. People are reporting that The Trivedi Effect® has beneficially changed their whole totality, everything from increased finances, better overall health, deeper and more loving relationships to better business opportunities, increased mental clarity, mental and emotional health and the rapid decline of psychological, neurological and many other physical disorders that Medical Science has found no effective or currently known cure. Thousands of client testimonials are available at http://www.triveditestimonials.com.

With these astounding results and the impressive compilation of supporting science research, human health care is highly anticipating the impact The Trivedi Effect® will have on Pharmaceuticals, Nutraceuticals and the rest of the world.

Alice Branton, CEO, Trivedi Global Inc., https://www.trivedimasterwellness.com/, +1 (706) 814-1140, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.